Related references
Note: Only part of the references are listed.TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells
Rui Cao et al.
CANCER LETTERS (2018)
Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation
M. Nakayama et al.
ONCOGENE (2017)
Impact of Ki67 re-assessmentat time of disease progression in patients with pancreatic neuroendocrine neoplasms
Francesco Panzuto et al.
PLOS ONE (2017)
TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1
Jia-chun Yang et al.
SCIENTIFIC REPORTS (2017)
Expression and clinical implication of S100A12 in gastric carcinoma
Dan Li et al.
TUMOR BIOLOGY (2016)
TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo
Jia Cao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells
Yu-Kun Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Intracellular distribution of TM4SF1 and internalization of TM4SF1-antibody complex in vascular endothelial cells
Tracey E. Sciuto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
USP10 Expression in Normal Adrenal Gland and Various Adrenal Tumors
Zhi Zeng et al.
ENDOCRINE PATHOLOGY (2015)
TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells
Biao Zheng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Novel Anti-TM4SF1 Antibody-Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature
Alberto Visintin et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer
Yuqi Su et al.
MOLECULAR MEDICINE REPORTS (2015)
Transmembrane-4-L-six-family-1, a potential predictor for poor prognosis, overexpressed in human glioma
Peng Wang et al.
NEUROREPORT (2015)
TM4SF1: a new vascular therapeutic target in cancer
Chi-Iou Lin et al.
ANGIOGENESIS (2014)
Prognostic significance of USP10 as a tumor-associated marker in gastric carcinoma
Zhi Zeng et al.
TUMOR BIOLOGY (2014)
TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1
Soo-Im Choi et al.
ONCOTARGET (2014)
A Novel HLA-A2-restricted CTL Epitope of Tumor-associated Antigen L6 can Inhibit Tumor Growth In Vivo
Shih-Hsin Tu et al.
JOURNAL OF IMMUNOTHERAPY (2012)
TM4SF1, A Novel Primary Androgen Receptor Target Gene Over-Expressed in Human Prostate Cancer and Involved in Cell Migration
Nathalie Allioli et al.
PROSTATE (2011)
Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma
Yao Zheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
The L6 Protein TM4SF1 Is Critical for Endothelial Cell Function and Tumor Angiogenesis
Shou-Ching Shih et al.
CANCER RESEARCH (2009)
The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility
Tamara Lekishvili et al.
JOURNAL OF CELL SCIENCE (2008)
Molecular and functional characterization of the four-transmembrane molecule L6 in epidermal keratinocytes
J Storim et al.
EXPERIMENTAL CELL RESEARCH (2001)
The L6 membrane proteins - A new four-transmembrane superfamily
MD Wright et al.
PROTEIN SCIENCE (2000)
Share Paper
